Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: dwc who wrote (19195)	4/17/1998 9:36:00 PM
From: Henry Niman	Respond to of 32384

09/21/95 MERRILL LYNCH CAPITAL MARKETS Ligand has a unique technology advantage: intracellular receptors as targets for small molecule drugs. Existing intracellular receptor (IR) targeted drugs already command a $5 billion annual worldwide market but have significant limitations that Ligand's technology could overcome. Five drug company partners in the development of IR compounds and two in a new technology, STATS, help validate Ligand's technology and management as well as manage cash burn rate. Allergan Ligand Retinoid Therapeutics (ALRT), a $100 million off-balance sheet entity, is a driver of near term products. Early clinical trial results in cancer with two compounds, LGD1069 and ALRT1057 topically in AIDS related Kaposi's sarcoma and cutaneous T-cell lymphoma are expected soon.

To: dwc who wrote (19195)	4/17/1998 9:42:00 PM
From: Henry Niman	Respond to of 32384

dwc, Merrill Lynch had covered LGND, but I believe that the analyst left. They have a very exclusive conference in Feb or March which is largely attended by big pharmas. LGND was invited in 1996. At the beginning of this year I asked if they would be attending and was told not THIS year. I used to get regular Merrill Lynch updates from a dermatologist friend. He actually claims to have bought LGND at the best public price ever. He put in a 1000 share buy at 5 1/2 and had 1/2 of his order filled at that price (in March of 1995). Needless to say, he is a bit more pleased with LGND's price action than bob (who I believe bought a year later at LGND's all time high of 19 3/4).